Keeping Pace With New HCV Treatment and Management Strategies: Steps for Success in Managed Care
Held in conjunction with AMCP 26th Annual Meeting & Expo

Thursday, April 3, 2014. 6:00 AM - 7:45 AM at the Tampa Convention Center, Room 20-21.

You may pre-register for this activity by clicking the link at the bottom of this page.

Hot Topics Include:
  • Expert review of current and emerging hepatitis C virus (HCV) treatments
  • Evolving strategies to manage patients with HCV
  • Update on current treatment guidelines for HCV
  • Determining the overall cost-effectiveness of HCV therapies
  • Innovative pharmacy benefit management strategies

Who Should Attend?
This activity is designed to meet the educational needs of pharmacists, physicians, and other health care professionals attending the AMCP's 26th Annual Meeting & Expo.

Program Overview
With the availability and future approval of protease inhibitors (PIs) for HCV, managed care organization (MCO) decision makers must consider many factors as they develop drug management strategies and tactics: drug costs, patient management needs, adherence, comparative safety and efficacy, and appropriate utilization management controls. Appropriate management strategies are critical for MCOs focused on ensuring that HCV patients receive optimal benefit from these therapies.

Educational Objectives
After completing this activity, the participant should be better able to:
  • Implement strategies to manage patients with HCV within a managed care setting
  • Utilize recently updated AASLD, IDSA, and ACG treatment guidelines on current and emerging treatment options for HCV, including efficacy, safety, and tolerability
  • Identify techniques for MCOs to determine the overall cost-effectiveness of HCV therapies
  • Evaluate pharmacy benefit management strategies, including methods that MCOs can implement to improve overall patient outcomes for HCV patients
  • Provide accurate and appropriate counsel as part of the treatment team.

Distinguished Faculty Presenters

Jeffrey D. Dunn, PharmD, MBA
Senior Vice President
VRx Pharmacy Services, LLC
Paul Y. Kwo, MD
Professor of Medicine
Division of Gastroenterology and Hepatology
Indiana University

Date and Time
Thursday, April 3, 2014
6:00 AM - 7:45 AM
Tampa Convention Center
Room 20-21
Tampa, FL

Agenda
6:00 AM Registration and Breakfast
6:15 AM Pre-activity Learning Assessment and Opening Comments
Jeffrey D. Dunn, PharmD, MBA
6:20 AM Improving Hepatitis C Virus (HCV) Treatment Success Rates: Challenges and Opportunities in a Managed Care Setting
Paul Y. Kwo, MD
6:45 AM Decision-Support Tools to Reduce Treatment Variability and Optimize Costs
Jeffrey D. Dunn, PharmD, MBA
7:00 AM Optimizing Therapeutic Decision-Making for the Treatment of HCV
Paul Y. Kwo, MD
7:20 AM Pharmacy Benefit Models and Specialty Management Services: Steps for Success
Jeffrey D. Dunn, PharmD, MBA
7:35 AM Audience Question and Answer Session
Key Takeaways and Closing Comments
Post-Activity Assessment and Evaluation

Continuing Education

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Pharmacist Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - (0809-9999-14-102-L01-P)

Upon receipt of the completed activity evaluation form, transcript information will be available at www .mycpemonitor.net within 4 weeks.

Type of Activity: Application-Based

Fee Information
There is no additional fee for participating in this activity.
Attendance at this symposium requires registration for AMCP's 26th Annual Meeting & Expo.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.


Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Click here to pre-register